Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00149734
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Unknown  Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Ondansetron;   Drug: Pill placebo;   Drug: Atypical antipsychotic drug

Indicates status has not been verified in more than two years